INTRODUCTION: Pancreatic adenocarcinoma is extremely rare in childhood. We report a case of metastatic pancreatic adenocarcinoma in a 13-year-old boy, revealed by jaundice. CASE PRESENTATION: A 13-year-old Moroccan boy was admitted with obstructive jaundice to the children's Hospital of Rabat, Department of Pediatric Oncology. Laboratory study results showed a high level of total and conjugated bilirubin. Computerized tomography of the abdomen showed a dilatation of the intra-hepatic and extra-hepatic bile ducts with a tissular heterogeneous tumor of the head of the pancreas and five hepatic lesions. Biopsy of a liver lesion was performed, and a histopathological examination of the sample confirmed the diagnosis of metastatic ductal adenocarcinoma of the pancreas. Our patient underwent a palliative biliary derivation. After that, chemotherapy was administered (5-fluorouracil and epirubicin), however no significant response to treatment was noted and our patient died six months after diagnosis. CONCLUSION: Malignant pancreatic tumors, especially ductal carcinomas, are exceedingly rare in the pediatric age group and their clinical features and treatment usually go unappreciated by most pediatric oncologists and surgeons.
INTRODUCTION:Pancreatic adenocarcinoma is extremely rare in childhood. We report a case of metastatic pancreatic adenocarcinoma in a 13-year-old boy, revealed by jaundice. CASE PRESENTATION: A 13-year-old Moroccan boy was admitted with obstructive jaundice to the children's Hospital of Rabat, Department of Pediatric Oncology. Laboratory study results showed a high level of total and conjugated bilirubin. Computerized tomography of the abdomen showed a dilatation of the intra-hepatic and extra-hepatic bile ducts with a tissular heterogeneous tumor of the head of the pancreas and five hepatic lesions. Biopsy of a liver lesion was performed, and a histopathological examination of the sample confirmed the diagnosis of metastatic ductal adenocarcinoma of the pancreas. Our patient underwent a palliative biliary derivation. After that, chemotherapy was administered (5-fluorouracil and epirubicin), however no significant response to treatment was noted and our patient died six months after diagnosis. CONCLUSION:Malignant pancreatic tumors, especially ductal carcinomas, are exceedingly rare in the pediatric age group and their clinical features and treatment usually go unappreciated by most pediatric oncologists and surgeons.
Authors: Nicholas A Shorter; Richard D Glick; David S Klimstra; Murray F Brennan; Michael P Laquaglia Journal: J Pediatr Surg Date: 2002-06 Impact factor: 2.545
Authors: Patrizia Dall'igna; Giovanni Cecchetto; Gianni Bisogno; Massimo Conte; Pierluigi Lelli Chiesa; Paolo D'Angelo; Francesco De Leonardis; Gianluca De Salvo; Francesca Favini; Andrea Ferrari Journal: Pediatr Blood Cancer Date: 2010-05 Impact factor: 3.167
Authors: David C Yu; Harry P Kozakewich; Antonio R Perez-Atayde; Robert C Shamberger; Christopher B Weldon Journal: J Pediatr Surg Date: 2009-12 Impact factor: 2.545
Authors: Eduardo A Perez; Juan C Gutierrez; Leonidas G Koniaris; Holly L Neville; William R Thompson; Juan E Sola Journal: J Pediatr Surg Date: 2009-01 Impact factor: 2.545